Discovering next-generation treatments for the mind and body

Enveric partners with top global institutions and experts to research and develop our synthesized molecules. Together, we are forging a fast path to pharmaceutical development, market entry and data collection and analysis.

Domain experience in cancer and cannabinoids

Facilities, research and innovation capabilities

AI-driven screening tools

Patient access
Research capabilities

Patient access
Research capabilities

Applied AI insights in mental health

Opportunity to Improve Outcomes in At-Risk Patients

Enveric Biosciences is leveraging their discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body.